These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14559101)

  • 1. New technologies in therapeutic antibody development.
    Brekke OH; Løset GÅ
    Curr Opin Pharmacol; 2003 Oct; 3(5):544-50. PubMed ID: 14559101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview on the use of therapeutic antibodies in drug discovery.
    Roguska M; Kaymakcalan Z; Salfeld J
    Curr Protoc Pharmacol; 2005 Jan; Chapter 9():Unit 9.7. PubMed ID: 22294129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant antibodies for cancer diagnosis and therapy.
    Hudson PJ; Souriau C
    Expert Opin Biol Ther; 2001 Sep; 1(5):845-55. PubMed ID: 11728219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies.
    Chartrain M; Chu L
    Curr Pharm Biotechnol; 2008 Dec; 9(6):447-67. PubMed ID: 19075685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage display-derived peptides as therapeutic alternatives to antibodies.
    Ladner RC; Sato AK; Gorzelany J; de Souza M
    Drug Discov Today; 2004 Jun; 9(12):525-9. PubMed ID: 15183160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: biopharmaceutical technologies.
    Jungbauer A
    Biotechnol J; 2007 Jun; 2(6):647. PubMed ID: 17570696
    [No Abstract]   [Full Text] [Related]  

  • 7. Phage display derived therapeutic antibodies.
    Thie H; Meyer T; Schirrmann T; Hust M; Dübel S
    Curr Pharm Biotechnol; 2008 Dec; 9(6):439-46. PubMed ID: 19075684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage display-derived human antibodies in clinical development and therapy.
    Frenzel A; Schirrmann T; Hust M
    MAbs; 2016 Oct; 8(7):1177-1194. PubMed ID: 27416017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic antibodies: Discovery, design and deployment.
    Ramsland PA; Hutchinson AT; Carter PJ
    Mol Immunol; 2015 Oct; 67(2 Pt A):1-3. PubMed ID: 25990602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrabodies as drug discovery tools and therapeutics.
    Stocks M
    Curr Opin Chem Biol; 2005 Aug; 9(4):359-65. PubMed ID: 15979379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Engineering for Biotherapeutics--IBC's second annual conference. Developing and improving next generation biotherapeutics.
    Smider V
    IDrugs; 2007 Mar; 10(3):176-7. PubMed ID: 17351870
    [No Abstract]   [Full Text] [Related]  

  • 12. Mating antibody phage display with proteomics.
    Hust M; Dübel S
    Trends Biotechnol; 2004 Jan; 22(1):8-14. PubMed ID: 14690617
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of therapeutic antibodies in drug discovery.
    Stockwin LH; Holmes S
    Biochem Soc Trans; 2003 Apr; 31(2):433-6. PubMed ID: 12653655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leveraging SBDD in protein therapeutic development: antibody engineering.
    Gilliland GL; Luo J; Vafa O; Almagro JC
    Methods Mol Biol; 2012; 841():321-49. PubMed ID: 22222459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody engineering and its applications in tumor targeting and intracellular immunization.
    Chames P; Baty D
    FEMS Microbiol Lett; 2000 Aug; 189(1):1-8. PubMed ID: 10913857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant antibodies and in vitro selection technologies.
    Geyer CR; McCafferty J; Dübel S; Bradbury AR; Sidhu SS
    Methods Mol Biol; 2012; 901():11-32. PubMed ID: 22723092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Antibodies by Phage Display.
    Shim H
    Curr Pharm Des; 2016; 22(43):6538-6559. PubMed ID: 27669967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.